Behr MA - Search Results

1

End-point definition and trial design to advance tuberculosis vaccine development.

Garcia-Basteiro AL, White RG, Tait D, Schmidt AC, Rangaka MX, Quaife M, Nemes E, Mogg R, Hill PC, Harris RC, Hanekom WA, Frick M, Fiore-Gartland A, Evans T, Dagnew AF, Churchyard G, Cobelens F, Behr MA, Hatherill M. Garcia-Basteiro AL, et al. Among authors: behr ma. Eur Respir Rev. 2022 Jun 7;31(164):220044. doi: 10.1183/16000617.0044-2022. Print 2022 Jun 30. Eur Respir Rev. 2022. PMID: 35675923 Free PMC article. Review.

2

Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial.

Hawkridge A, Hatherill M, Little F, Goetz MA, Barker L, Mahomed H, Sadoff J, Hanekom W, Geiter L, Hussey G; South African BCG trial team. Hawkridge A, et al. BMJ. 2008 Nov 13;337:a2052. doi: 10.1136/bmj.a2052. BMJ. 2008. PMID: 19008268 Free PMC article. Clinical Trial.

3

Consensus statement on diagnostic end points for infant tuberculosis vaccine trials.

Hatherill M, Verver S, Mahomed H; Taskforce on Clinical Research Issues, Stop TB Partnership Working Group on TB Vaccines. Hatherill M, et al. Clin Infect Dis. 2012 Feb 15;54(4):493-501. doi: 10.1093/cid/cir823. Epub 2011 Dec 5. Clin Infect Dis. 2012. PMID: 22144538

4

Tuberculosis.

Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, Ginsberg A, Swaminathan S, Spigelman M, Getahun H, Menzies D, Raviglione M. Pai M, et al. Among authors: behr ma. Nat Rev Dis Primers. 2016 Oct 27;2:16076. doi: 10.1038/nrdp.2016.76. Nat Rev Dis Primers. 2016. PMID: 27784885 Review.

5

Progression to tuberculosis disease increases with multiple exposures.

Lee RS, Proulx JF, Menzies D, Behr MA. Lee RS, et al. Among authors: behr ma. Eur Respir J. 2016 Dec;48(6):1682-1689. doi: 10.1183/13993003.00893-2016. Epub 2016 Oct 6. Eur Respir J. 2016. PMID: 27824599 Free article.

6

Cracking the Vaccine Code in Tuberculosis.

Divangahi M, Behr MA. Divangahi M, et al. Among authors: behr ma. Am J Respir Crit Care Med. 2018 Feb 15;197(4):427-432. doi: 10.1164/rccm.201707-1489PP. Am J Respir Crit Care Med. 2018. PMID: 29045159 Review. No abstract available.

7

Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.

Behr MA, Divangahi M, Schurr E. Behr MA, et al. J Infect Dis. 2021 Feb 3;223(2):189-191. doi: 10.1093/infdis/jiaa637. J Infect Dis. 2021. PMID: 33535239 Free PMC article.

8

Comparative genomics of BCG vaccines.

Behr MA. Behr MA. Tuberculosis (Edinb). 2001;81(1-2):165-8. doi: 10.1054/tube.2000.0253. Tuberculosis (Edinb). 2001. PMID: 11463238 Review.

9

Comparative genomics in the fight against tuberculosis: diagnostics, epidemiology, and BCG vaccination.

Mostowy S, Behr MA. Mostowy S, et al. Among authors: behr ma. Am J Pharmacogenomics. 2002;2(3):189-96. doi: 10.2165/00129785-200202030-00004. Am J Pharmacogenomics. 2002. PMID: 12383025 Review.

10

Tuberculosis in the Inuit community of Quebec, Canada.

Nguyen D, Proulx JF, Westley J, Thibert L, Dery S, Behr MA. Nguyen D, et al. Among authors: behr ma. Am J Respir Crit Care Med. 2003 Dec 1;168(11):1353-7. doi: 10.1164/rccm.200307-910OC. Epub 2003 Sep 18. Am J Respir Crit Care Med. 2003. PMID: 14500266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

259 results

Search Page